Michelle Dockhorn, M.B.A., Ph.D., an executive with extensive marketing and business development leadership experience specific to the life science industry, has joined SCORR Marketing as vice president of global markets. Dockhorn brings 20 years of experience to SCORR.

“Michelle has worked with organizations around the world, from startups to some of the biggest companies in this industry,” said Cinda Orr, SCORR president and chief executive officer. “By applying her vast experience, she has helped them build dynamic marketing programs, increase their sales and grow their businesses. Michelle understands the complexities of the drug development services industry, and our clients will find her knowledge and experience to be a great resource.”

Dockhorn began her career in drug development with National Medical Research (now SciRex), in data management, statistics, medical writing and quality assurance. She was a clinical scientist for Bristol-Myers Squibb before joining PRA, where she became vice president of global business development.

Dockhorn has served as an executive consultant in marketing, sales and business development roles for several companies in the drug development services industry, including Focus Bio-Inova, Nextrials, Logical Therapeutics, CR and Trio Clinical Research, which has since become a part of Aptiv Solutions.